Literature DB >> 35308474

Micro-elimination of Hepatitis C in Low- and Middle-Income Settings: Challenges and Windows of Opportunity.

Enrique Wolpert Barraza1, David Kershenobich Stalnikowitz2, Jorge Enrique Guerrero Guerrero3, Alethse de la Torre Rosas4.   

Abstract

Content available: Author Interview and Audio Recording.
© 2021 American Association for the Study of Liver Diseases.

Entities:  

Year:  2021        PMID： 35308474      PMCID： PMC8912219          DOI： 10.1002/cld.1152

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  7 in total

1.  Hepatitis C screening in the general population.

Authors:  Clara Corona-Lau; Linda Muñoz; Enrique Wolpert; Luz Ma Aguilar; Margarita Dehesa; Concepción Gutiérrez; David Kershenobich
Journal:  Rev Invest Clin       Date:  2015 Mar-Apr       Impact factor: 1.451

2.  Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.

Authors:  Omar Silverman-Retana; Edson Serván-Mori; Sandra I McCoy; Sarah Larney; Sergio Bautista-Arredondo
Journal:  Drug Alcohol Depend       Date:  2017-10-14       Impact factor: 4.492

3.  Chronic Hepatitis C Treatment with Direct-Acting Antiviral Agents in a Real-Life Setting.

Authors:  Ruby Ann Chirino-Sprung; Margarita Dehesa; Enrique Wolpert; Clara Corona-Lau; Ignacio García-Juarez; José Francisco Sánchez-Ávila; Carlos Moctezuma-Velázquez; David Kershenobich
Journal:  Rev Invest Clin       Date:  2016 Jul-Aug       Impact factor: 1.451

4.  Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico.

Authors:  Nahum Méndez-Sánchez; Daniel Motola-Kuba; Norberto C Chavez-Tapia; Jesús Bahena; Ricardo Correa-Rotter; Misael Uribe
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

5.  Hepatitis C virus infection among HIV-1 infected individuals from northern Mexico.

Authors:  Ana M Rivas-Estilla; Eda Ramírez-Valles; Ramón Martinez-Hernández; Claudia Charles-Niño; Ericka Ramírez-Camacho; Felix Rositas-Noriega; Maria L Garza-Rodriguez; Hugo A Barrera-Saldaña; Karina Trujillo-Murillo; Javier Ramos-Jimenez
Journal:  Hepatol Res       Date:  2007-05       Impact factor: 4.288

6.  High-risk sexual and drug using behaviors among male injection drug users who have sex with men in 2 Mexico-US border cities.

Authors:  Robert G Deiss; Kimberly C Brouwer; Oralia Loza; Remedios M Lozada; Rebeca Ramos; Michelle A Firestone Cruz; Thomas L Patterson; Douglas D Heckathorn; Simon D Frost; Steffanie A Strathdee
Journal:  Sex Transm Dis       Date:  2008-03       Impact factor: 2.830

7.  Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.

Authors:  Pablo F Belaunzarán-Zamudio; Juan L Mosqueda-Gomez; Alejando Macias-Hernandez; Juan G Sierra-Madero; Saifuddin Ahmed; Chris Beyrer
Journal:  PLoS One       Date:  2017-06-27       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.